Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2008
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
10/07/2008US7432354 Polypeptide or fragment recognized by tumor-specific cytotoxic T lymphocytes; anticancer vaccines
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation
10/07/2008US7432292 Anticancer agents; autoimmune diseases; antiinflammatory agents; ; graft versus host disease; Crohn's diseases; skin disorders
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
10/07/2008US7431953 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
10/07/2008CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof
10/07/2008CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
10/07/2008CA2259984C Precise efficacy assay methods for active agents including chemotherapeutic agents
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2209426C Human pak65
10/05/2008CA2583999A1 Characterization of a mekk binding site and uses thereof
10/04/2008CA2639579A1 Pi3 kinase antagonists
10/02/2008WO2008118823A2 Compositions and methods for inhibition of the jak pathway
10/02/2008WO2008118792A2 Gamma delta t cells and methods of treatment of interleukin-17 related conditions
10/02/2008WO2008118587A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117019A1 Tlr4 ligand isolated from honey
10/02/2008WO2008116816A1 Combination of cb2 ligand and paracetamol
10/02/2008WO2008116470A1 Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor
10/02/2008WO2008116380A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008WO2008116293A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008WO2008100618A3 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/02/2008WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
10/02/2008WO2008078056A3 Method for amplifying hcv in aedes mosquitoes
10/02/2008WO2008073463A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/02/2008WO2008033655A3 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
10/02/2008US20080242855 Process for Producing Flavone C Glycoside Derivatives
10/02/2008US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders
10/02/2008US20080242713 alpha -[hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octenyl)-2H-cyclopenta[b]furan-2-ylidene]-1H-tetrazole-5-2E-pentanenitrile; inhibits release of Th-1 cytokines while sparing expression of Th-2 cytokines; multiple sclerosis, psoriasis, rheumatoid arthritis, Crohn's disease, alopecia areata
10/02/2008US20080242704 selectively modulate, regulate, and/or inhibit signal transduction; potent and selective c-kit, bcr-abl and Fit-3 inhibitors; diseases like cell proliferation, metabolic, allergic, cancers, degenerative, autoimmune disorders; 4-{2-[5-(Benzothiazol-2-ylammo)-2-methyl-phenylamino]-oxazol-5-yl}-benzonitrile
10/02/2008US20080242654 Novel compounds as cannabinoid receptor ligands
10/02/2008US20080242628 In vivo
10/02/2008US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241268 Compositions and methods for wt1 specific immunotherapy
10/02/2008US20080241237 Taste-masked microparticles of hydroxyzine, cetirizine (hydrochloride), efletirizine, meclizine, buclizine or levocetirizine dihydrochloride coated with a taste-masking coating of a water insoluble polymer and an enteric polymer; orally disintegrating tablets; storage stability
10/02/2008US20080241195 Optimal Polyvalent Vaccine for Cancer
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241193 An expression vector for Leishmania kinetoplastid membrane protein 11 antigen or an epitope thereof, from a recombinant canarypox virus; prime-boost administration regimen; prevents diffusion and implantation of parasite into internal organs
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241184 Canine influenza vaccines
10/02/2008US20080241182 Mycobacterial polypeptide for use in producing vaccine to prevent grampositive bacterial infection
10/02/2008US20080241181 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241177 Idiotypic vaccine
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241171 Stem Cell Populations and Methods of Use
10/02/2008US20080241170 Increasing effectiveness of antigen cells expressing dendritic cell inhibitory receptor (DCIR); tissue targeted therapy
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241163 Tweak binding antibodies
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241141 Using multispecific antagonist for use in treatment and prevention of infection, cell proliferative, inflammatory and autoimmune disorders
10/02/2008US20080241139 Therapeutic mixture comprising toll-like receptor, CD40 and tumor necrosis factor agonist for use in treatment and prevention of cell proliferative and viral diseases
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241075 Parasite Vaccine
10/02/2008US20080241069 Methods and compositions for treating IgE-mediated diseases
10/02/2008DE202008006598U1 Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung Allergy vaccine formulation for mucosal administration
10/02/2008CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2681775A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681728A1 Combination of blys inhibition and/or april inhibition and immunosuppressants for treatment of autoimmune disease
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975174A1 Selective peptides that inhibit the biological activity of calcineurin
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors
10/01/2008EP1975171A1 Anti-tumor agent and immunostimulating agent
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974740A1 Use of tgf-beta 1 inhibitor peptides in the preparation of an immune response modulating agent
10/01/2008EP1974019A1 Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 1172